Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Therapy for Severe COVID-19
NCT04445454Phase 2Recruiting
- Sponsor
- University of Liège
- Start
- Jun 2020
- Primary completion
- Sep 2024
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Provacel in COVID-19 pneumonia, sponsored by University of Liège. Started Jun 2020; status: recruiting.
02
Drugs
Provacel
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04445454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04445454.